Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06656923 · ClinicalTrials.gov registry record
Analyze Previously Collected Biopsy Samples From Participants Who Completed the "SPLASH: Split-Body Randomized Clinical Trial of Poly-L-Lactic Acid for Adipogenesis and Volumization of the Hip Dell" Study
A clinical trial of Lateral Gluteal Depression, sponsored by Goldman, Butterwick, Fitzpatrick and Groff.
- Active
- Registry status
- 14
- Enrollment target
- 1
- Study location
NCT06656923 is a study of Lateral Gluteal Depression that is active but no longer recruiting, run by Goldman, Butterwick, Fitzpatrick and Groff. The registered enrollment target is 14 participants. The trial reports 1 study location across 1 state.
The verdict
NCT06656923, a study of Lateral Gluteal Depression, is active but no longer recruiting, sponsored by Goldman, Butterwick, Fitzpatrick and Groff.
- ACTIVE NOT RECRUITING
- Registry status
- 14 participants
- Enrollment target
- 1
- Study location
Study Summary
Primary Objective: use immunofluorescence (IF) on previously obtained biopsies to analyze and quantify changes in adipose tissue of subjects injected with poly-L-lactic acid (PLLA) or saline.
Conditions Studied
Interventions
- DIAGNOSTIC_TEST Biopsies
Study Locations (1)
California
- Cosmetic Laser Dermatology/West Dermatology Research Center - San Diego
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 14 participants |
| Start Date | 2024-11-01 |
| Est. Completion | 2025-08-30 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06656923
The ClinicalTrials.gov registry entry for NCT06656923 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 14 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Goldman, Butterwick, Fitzpatrick and Groff, which has 18 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Lateral Gluteal Depression appearing as the primary indexed condition, and to 1 intervention - of which Biopsies is the first listed.
NCT06656923 reports 1 study location spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT06656923 about?
NCT06656923 is a clinical study titled "Analyze Previously Collected Biopsy Samples From Participants Who Completed the "SPLASH: Split-Body Randomized Clinical Trial of Poly-L-Lactic Acid for Adipogenesis and Volumization of the Hip Dell" Study". Primary Objective: use immunofluorescence (IF) on previously obtained biopsies to analyze and quantify changes in adipose tissue of subjects injected with poly-L-lactic acid (PLLA) or saline.
What is the current status of trial NCT06656923?
This trial is currently active not recruiting. The enrollment target is 14 participants. The study started on 2024-11-01. Estimated completion is 2025-08-30.
What conditions does trial NCT06656923 study?
This clinical trial studies the following conditions: Lateral Gluteal Depression.
What interventions are being tested in trial NCT06656923?
The interventions under investigation include: Biopsies (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT06656923?
This trial is sponsored by Goldman, Butterwick, Fitzpatrick and Groff, which has 18 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06656923 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.